Board of Trustees of The Leland Stanford Junior University’s PTC Therapeutics PTCT Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10,295	Closed	-$533K	–	34
2014 Q4	$533K	Hold	10,295	–	–	0.15%	22
2014 Q3	$453K	Hold	10,295	–	–	0.23%	23
2014 Q2	$269K	Buy	+10,295	New	+$220K	0.25%	9

Other funds holding PTCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's PTCT Position: Q1 2015 in Review

Board of Trustees of The Leland Stanford Junior University sold out of PTC Therapeutics (PTCT) in Q1 2015, closing a stake of 10,295 shares — an estimated $533K sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in PTCT in Q2 2014 and held it in 3 quarters. The position peaked at $533K in Q4 2014. 157 funds tracked by Wall St. Rank hold PTCT as of Q1 2015.

Board of Trustees of The Leland Stanford Junior University reported no remaining PTC Therapeutics position as of Q1 2015 after selling out during the quarter.
Board of Trustees of The Leland Stanford Junior University sold 10,295 PTC Therapeutics shares in Q1 2015, an estimated $533K.
Board of Trustees of The Leland Stanford Junior University first reported a position in PTC Therapeutics in Q2 2014 and held it in 3 quarters.
Board of Trustees of The Leland Stanford Junior University's PTC Therapeutics position peaked at $533K in Q4 2014.
157 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2015.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q1 2015, filed 12 May 2015.